TY  - JOUR 
AU  - Arenal, Ángel
AU  - Ávila, Pablo
AU  - Jiménez Candil, Francisco Javier
AU  - Tercedor, Luis
AU  - Calvo, David
AU  - Arribas, Fernando
AU  - Fernández-Portales, Javier
AU  - Merino, José Luis
AU  - Hernández Madrid, Antonio
AU  - Fernández-Avilés, Francisco J.
AU  - Berruezo, Antonio
PY  - 2022
SN  - 0735-1097
UR  - http://hdl.handle.net/10366/161305
AB  - [EN]In patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but the most effective approach remains uncertain.
This trial compares the efficacy...
LA  - eng
PB  - Elsevier
KW  - Catheter ablation
KW  - Amiodarone
KW  - Ventricular tachycardia
KW  - Cardiomyopathies
KW  - Aged
KW  - Prospective Studies
KW  - Amiodarone
KW  - Anti-Arrhythmia Agents
KW  - Treatment Outcome
KW  - Humans
KW  - Defibrillators
KW  - Tachycardia
KW  - Myocardial Ischemia
KW  - Catheter Ablation
KW  - Heart Failure
TI  - Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia
DO  - 10.1016/j.jacc.2022.01.050
T2  - Journal of the American College of Cardiology
VL  - 79
M2  - 1441
ER  -